Furthermore, Kaplan-Meier survival analysis revealed that the higher expression of VAMP5, TIGIT, LCK, CHORDC1, CD27, and CACYBP was correlated with better outcomes in bladder cancer patients treated with immunotherapy (Fig. 2B). This evidence concerns the gene TIGIT and urinary bladder carcinoma.